Literature DB >> 18331587

Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism.

Tanya L Daigle1, Mary Lee Kwok, Ken Mackie.   

Abstract

Agonists stimulate cannabinoid 1 receptor (CB(1)R) internalization. Previous work suggests that the extreme carboxy-terminus of the receptor regulates this internalization - likely through the phosphorylation of serines and threonines clustered within this region. While truncation of the carboxy-terminus (V460Z CB(1)) and consequent removal of these putative phosphorylation sites prevents endocytosis in AtT20 cells, the residues necessary for CB(1)R internalization remain elusive. To determine the structural requirements for internalization, we evaluated endocytosis of carboxy-terminal mutant CB(1)Rs stably expressed in HEK293 cells. In contrast to AtT20 cells, V460Z CB(1)R expressed in HEK293 cells internalized to the same extent and with similar kinetics as the wild-type receptor. However, mutation of serine and/or threonine residues within the extreme carboxy-terminal attenuated internalization when these receptors were expressed in HEK293 cells. These results establish that the extreme carboxy-terminal phosphorylation sites are not required for internalization of truncated receptors, but are required for internalization of full-length receptors in HEK293 cells. Analysis of beta-arrestin-2 recruitment to mutant CB(1)R suggests that putative carboxy-terminal phosphorylation sites mediate beta-arrestin-2 translocation. This study indicates that the local cellular environment affects the structural determinants of CB(1)R internalization. Additionally, phosphorylation likely regulates the internalization of (full-length) CB(1)Rs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331587      PMCID: PMC3707135          DOI: 10.1111/j.1471-4159.2008.05336.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  39 in total

Review 1.  Desensitization of G protein-coupled receptors and neuronal functions.

Authors:  Raul R Gainetdinov; Richard T Premont; Laura M Bohn; Robert J Lefkowitz; Marc G Caron
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

2.  Historical review: a brief history and personal retrospective of seven-transmembrane receptors.

Authors:  Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2004-08       Impact factor: 14.819

3.  A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation.

Authors:  L S Barak; S S Ferguson; J Zhang; M G Caron
Journal:  J Biol Chem       Date:  1997-10-31       Impact factor: 5.157

4.  Phosphorylation is not required for dynamin-dependent endocytosis of a truncated mutant opioid receptor.

Authors:  S R Murray; C J Evans; M von Zastrow
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

5.  Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

Authors:  M Bouaboula; C Poinot-Chazel; B Bourrié; X Canat; B Calandra; M Rinaldi-Carmona; G Le Fur; P Casellas
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

6.  Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

Authors:  K Mackie; Y Lai; R Westenbroek; R Mitchell
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

7.  Agonist-induced internalization of leukotriene B(4) receptor 1 requires G-protein-coupled receptor kinase 2 but not arrestins.

Authors:  Zhangguo Chen; Rémi Gaudreau; Christian Le Gouill; Marek Rola-Pleszczynski; Jana Stanková
Journal:  Mol Pharmacol       Date:  2004-09       Impact factor: 4.436

8.  Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.

Authors:  A C Howlett; R M Fleming
Journal:  Mol Pharmacol       Date:  1984-11       Impact factor: 4.436

9.  Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.

Authors:  K Mackie; B Hille
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

10.  Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation.

Authors:  J E Heuser; R G Anderson
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  49 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Chem Inf Model       Date:  2019-12-10       Impact factor: 4.956

3.  Acute ethanol exposure reduces serotonin receptor 1A internalization by increasing ubiquitination and degradation of β-arrestin2.

Authors:  Deborah J Luessen; Haiguo Sun; Molly M McGinnis; Michael Hagstrom; Glen Marrs; Brian A McCool; Rong Chen
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

4.  The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones.

Authors:  Alex Straiker; Jim Wager-Miller; Ken Mackie
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Characterization of the endocannabinoid system, CB(1) receptor signalling and desensitization in human myometrium.

Authors:  Paul J Brighton; Timothy H Marczylo; Shashi Rana; Justin C Konje; Jonathon M Willets
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

6.  Hydrophobic residues in helix 8 of cannabinoid receptor 1 are critical for structural and functional properties.

Authors:  Kwang H Ahn; Akiko Nishiyama; Dale F Mierke; Debra A Kendall
Journal:  Biochemistry       Date:  2010-01-26       Impact factor: 3.162

7.  Two Janus Cannabinoids That Are Both CB2 Agonists and CB1 Antagonists.

Authors:  Amey Dhopeshwarkar; Natalia Murataeva; Alex Makriyannis; Alex Straiker; Ken Mackie
Journal:  J Pharmacol Exp Ther       Date:  2016-12-07       Impact factor: 4.030

8.  Sequence-Specific Regulation of Endocytic Lifetimes Modulates Arrestin-Mediated Signaling at the µ Opioid Receptor.

Authors:  Zara Y Weinberg; Amanda S Zajac; Tiffany Phan; Daniel J Shiwarski; Manojkumar A Puthenveedu
Journal:  Mol Pharmacol       Date:  2017-02-02       Impact factor: 4.436

9.  Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Authors:  Giuseppe Tortoriello; Claudia V Morris; Alan Alpar; Janos Fuzik; Sally L Shirran; Daniela Calvigioni; Erik Keimpema; Catherine H Botting; Kirstin Reinecke; Thomas Herdegen; Michael Courtney; Yasmin L Hurd; Tibor Harkany
Journal:  EMBO J       Date:  2014-01-27       Impact factor: 11.598

10.  Illuminating the life of GPCRs.

Authors:  Ilka Böhme; Annette G Beck-Sickinger
Journal:  Cell Commun Signal       Date:  2009-07-14       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.